Cullinan Therapeutics Inc (CGEM)
15.61
-0.18
(-1.14%)
USD |
NASDAQ |
Nov 14, 10:22
Cullinan Therapeutics 1 Year Total Returns (Daily): 80.05% for Nov. 13, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 13, 2024 | 80.05% |
November 12, 2024 | 76.24% |
November 11, 2024 | 89.99% |
November 08, 2024 | 61.17% |
November 07, 2024 | 58.01% |
November 06, 2024 | 68.16% |
November 05, 2024 | 61.09% |
November 04, 2024 | 60.48% |
November 01, 2024 | 70.04% |
October 31, 2024 | 66.67% |
October 30, 2024 | 86.65% |
October 29, 2024 | 100.7% |
October 28, 2024 | 91.58% |
October 25, 2024 | 87.32% |
October 24, 2024 | 85.06% |
October 23, 2024 | 85.61% |
October 22, 2024 | 82.70% |
October 21, 2024 | 85.57% |
October 18, 2024 | 85.51% |
October 17, 2024 | 92.57% |
October 16, 2024 | 97.42% |
October 15, 2024 | 84.55% |
October 14, 2024 | 84.43% |
October 11, 2024 | 86.01% |
October 10, 2024 | 78.72% |
Date | Value |
---|---|
October 09, 2024 | 76.57% |
October 08, 2024 | 83.90% |
October 07, 2024 | 83.10% |
October 04, 2024 | 101.2% |
October 03, 2024 | 97.55% |
October 02, 2024 | 96.78% |
October 01, 2024 | 85.19% |
September 30, 2024 | 84.97% |
September 27, 2024 | 69.53% |
September 26, 2024 | 72.65% |
September 25, 2024 | 68.63% |
September 24, 2024 | 85.99% |
September 23, 2024 | 75.24% |
September 20, 2024 | 90.45% |
September 19, 2024 | 75.20% |
September 18, 2024 | 71.44% |
September 17, 2024 | 73.09% |
September 16, 2024 | 69.98% |
September 13, 2024 | 82.05% |
September 12, 2024 | 67.33% |
September 11, 2024 | 69.94% |
September 10, 2024 | 73.01% |
September 09, 2024 | 77.18% |
September 06, 2024 | 61.98% |
September 05, 2024 | 59.52% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-74.87%
Minimum
Mar 31 2022
206.4%
Maximum
May 07 2024
-2.41%
Average
-20.73%
Median
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -74.28% |
AIM ImmunoTech Inc | -44.75% |
IGC Pharma Inc | 19.61% |
NovaBay Pharmaceuticals Inc | -93.43% |
Protalix BioTherapeutics Inc | -8.15% |